HYDROXYCHLOROQUINE SULFATE (hydroxychloroquine) by Molecular Devices is 12. Approved for acute, chronic rheumatoid arthritis in adults, systemic lupus erythematosus in adults and 6 more indications. First approved in 2018.
Drug data last refreshed 21h ago
12.1 Mechanism of Action Malaria Hydroxychloroquine is a 4-aminoquinoline antimalarial [see ] and antirheumatic agent. Rheumatoid Arthritis, Systemic Lupus Erythematosus and Chronic Discoid Lupus Erythematosus The mechanisms underlying the anti-inflammatory and immunomodulatory effects of…
Worked on HYDROXYCHLOROQUINE SULFATE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer